Classic Galactosemia
For the why behind the fact
Use this page to connect what you are memorizing.
Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.
Overview
Plain-Language Overview
A baby with classic galactosemia cannot process galactose normally. Breast milk and standard milk formula contain lactose, which releases galactose during digestion. Within days, a newborn may feed poorly, vomit, turn yellow or develop a serious bloodstream infection. Prompt replacement with a suitable infant formula helps prevent acute liver failure. Speech, movement or reproductive problems can still develop despite early treatment.
Clinical Definition
Classic galactosemia is autosomal recessive deficiency of galactose-1-phosphate uridylyltransferase (GALT). After lactose feeding, galactose-1-phosphate accumulates and surplus galactose is reduced to galactitol. Think of a newborn with jaundice, hepatomegaly, poor feeding and E. coli sepsis. Galactitol draws water into the lens and can cause cataracts. Feeding changes are urgent while confirmation is pending.
Inciting Event
Introduction of galactose-containing milk or formula triggers symptom onset.
Exposure to lactose in breast milk or cow’s milk formula initiates toxic metabolite accumulation.
Failure to metabolize galactose after birth leads to rapid clinical deterioration.
Latency Period
Severe illness may begin within days of starting breast milk or standard lactose-containing formula.
Clinical signs appear rapidly as toxic metabolites accumulate in tissues.
Delay in symptom onset beyond neonatal period is uncommon in classic galactosemia.
Diagnostic Delay
Early symptoms such as jaundice and vomiting are nonspecific and often attributed to common neonatal conditions.
Lack of routine newborn screening in some areas delays diagnosis.
E. coli sepsis can be the first clue to classic galactosemia. A positive culture should prompt treatment of infection alongside evaluation of milk-triggered liver injury.
Failure to recognize the significance of feeding intolerance and hepatomegaly in neonates.
Clinical Presentation
Signs & Symptoms
Vomiting and diarrhea shortly after milk ingestion
Jaundice and hepatomegaly in the neonatal period
Cataracts developing within the first few weeks of life
Lethargy and hypotonia indicating central nervous system involvement
Lethargy, poor feeding or temperature instability may indicate true neonatal sepsis, classically due to E. coli.
History of Present Illness
Onset of poor feeding, vomiting, and lethargy within days to weeks after starting milk feeding.
Development of jaundice, hepatomegaly, and failure to thrive in the neonatal period.
A newborn may develop hypoglycemia, coagulopathy and E. coli bacteremia during the same illness.
Infants may exhibit cataracts and hypotonia as disease progresses without treatment.
Past Medical History
Typically no prior medical history as symptoms begin in the neonatal period.
Absence of prior illnesses but history of feeding with lactose-containing formula or breast milk is critical.
No history of metabolic disorders unless previously diagnosed in siblings.
Family History
Presence of siblings with similar neonatal illness or early death suggests autosomal recessive inheritance.
Known family history of classic galactosemia or carrier status in parents.
Consanguinity or ethnic background with higher prevalence increases suspicion.
Physical Exam Findings
Jaundice with scleral icterus due to hepatic dysfunction
Hepatomegaly from liver inflammation and damage
Cataracts visible on slit-lamp examination in infants
Failure to thrive with poor weight gain and growth retardation
Hypotonia and developmental delay in untreated cases
Diagnostic Workup
Diagnostic Criteria
A positive newborn screen requires urgent metabolic evaluation. Confirm with markedly reduced or absent erythrocyte GALT activity, erythrocyte galactose-1-phosphate and/or two pathogenic GALT variants in trans. A recent red-cell transfusion may mask deficient enzyme activity. Give the laboratory the transfusion and feeding history, and use specialist-directed molecular testing when needed.
Pathophysiology
Key Mechanisms
GALT normally transfers a uridylyl group from UDP-glucose to galactose-1-phosphate, forming UDP-galactose and glucose-1-phosphate. Loss of this step increases galactose-1-phosphate.
Accumulation of galactitol via aldose reductase causes osmotic damage in lens and other tissues.
Impaired galactose metabolism disrupts energy production and cellular function in liver, brain, and kidneys.
Toxic metabolites cause hepatocellular injury, leading to jaundice and hepatomegaly.
Accumulation of galactose metabolites in the brain contributes to intellectual disability and neurologic deficits.
| Involvement | Details |
|---|---|
| Organs | Liver is the primary organ affected, showing hepatomegaly, jaundice, and potential liver failure. |
Eyes develop cataracts due to galactitol accumulation in the lens. | |
Brain involvement leads to intellectual disability and motor dysfunction in untreated patients. | |
| Tissues | Liver tissue is damaged by toxic metabolite accumulation leading to hepatomegaly, jaundice, and fibrosis. |
Lens tissue undergoes osmotic swelling and damage resulting in cataracts. | |
Brain tissue may show developmental abnormalities and neuronal loss contributing to cognitive impairment. | |
| Cells | Hepatocytes are critically affected due to accumulation of toxic galactose-1-phosphate causing liver dysfunction. |
Lens epithelial cells accumulate galactitol leading to osmotic damage and formation of cataracts. | |
Neurons may be damaged by toxic metabolites contributing to long-term neurological deficits. | |
| Chemical Mediators | Galactose-1-phosphate accumulates due to deficient galactose-1-phosphate uridyltransferase activity, causing cellular toxicity. |
Galactitol accumulates in the lens, causing osmotic stress and cataract formation. | |
The block disrupts UDP-sugar metabolism. Mechanisms of persistent neurologic and ovarian complications are incompletely understood. |
Treatments
Pharmacological Treatments
No disease-specific pharmacological treatment is listed for this topic.
Non-pharmacological Treatments
On suspicion, stop breast milk and standard lactose-containing formula immediately. Start an appropriate galactose-restricted infant formula such as soy infant formula with urgent metabolic-team guidance, before confirmatory results.
Supportive management of complications such as cataracts and liver dysfunction with appropriate specialist care.
Regular monitoring of growth, development, and neurological status to guide supportive interventions.
Prevention
Pharmacological Prevention
No established pharmacological prophylaxis exists for classic galactosemia
Dietary treatment is the standard intervention. Evaluate acute complications and treat infections promptly.
Assess calcium and vitamin D intake during dairy restriction and supplement when intake or measured status is inadequate.
Non-pharmacological Prevention
Newborn screening for early detection of GALT deficiency
Continue lifelong restriction of major dairy galactose sources. Fruits, vegetables and legumes are generally permitted.
For infants, use a metabolic-team-approved nutritionally complete formula. Ordinary plant beverages are unsuitable substitutes for infant formula.
Genetic counseling for families with known GALT mutations
Regular monitoring of growth, development, and organ function to prevent complications
Outcome & Complications
Complications
Liver failure from progressive hepatic damage
E. coli sepsis can accompany acute liver disease. Obtain cultures and start empiric neonatal sepsis treatment promptly in an ill newborn.
Cataract formation causing visual impairment
Neurological impairment including intellectual disability and ataxia
Primary ovarian insufficiency is common in affected females even with early treatment. Fertility is reduced, but spontaneous pregnancy can occur.
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Classic Galactosemia versus Hereditary Fructose Intolerance
Classic Galactosemia | Hereditary Fructose Intolerance |
|---|---|
Symptoms triggered by ingestion of galactose or lactose-containing foods | Symptoms triggered by ingestion of fructose, sucrose, or sorbitol |
Elevated galactose-1-phosphate in erythrocytes and tissues | Aldolase B deficiency traps phosphate as intracellular fructose-1-phosphate and impairs glycogenolysis and gluconeogenesis, causing hypoglycemia after fructose exposure. |
Very low erythrocyte GALT activity and/or biallelic pathogenic GALT variants establish the cause. | Biallelic pathogenic ALDOB variants confirm hereditary fructose intolerance. Avoid a diagnostic fructose challenge. |
Classic Galactosemia versus Neonatal Sepsis
Classic Galactosemia | Neonatal Sepsis |
|---|---|
Poor feeding and liver injury typically follow milk exposure within days. | Neonatal sepsis can occur during this same period and may complicate galactosemia. |
Low erythrocyte GALT and high erythrocyte galactose-1-phosphate support the metabolic diagnosis even with a positive blood culture. | Culture can identify invasive bacteria. E. coli bacteremia in a jaundiced milk-fed newborn strengthens concern for galactosemia. |
Replace lactose-containing feeds immediately and treat suspected sepsis concurrently. | Start empiric antibiotics promptly after obtaining cultures when feasible. Infection treatment alone leaves the dietary trigger in place. |
Classic Galactosemia versus Galactokinase Deficiency
Classic Galactosemia | Galactokinase Deficiency |
|---|---|
Erythrocyte galactose-1-phosphate rises and urinary galactitol can be elevated. | The upstream galactokinase block limits galactose-1-phosphate formation. Galactose and galactitol rise while GALT activity is preserved. |
Cataracts may accompany severe liver disease and E. coli sepsis. | Cataracts often dominate in galactokinase deficiency, with the infant otherwise well. |
Deficiency of GALT enzyme activity | Deficiency of galactokinase enzyme activity |
Classic Galactosemia versus Tyrosinemia Type I
Classic Galactosemia | Tyrosinemia Type I |
|---|---|
Elevated galactose-1-phosphate and galactitol without succinylacetone | Elevated blood or urine succinylacetone is the characteristic marker. Tyrosine alone is nonspecific. |
Milk-triggered hepatic injury, cataracts or E. coli sepsis suggest GALT deficiency. Renal tubular dysfunction can also occur. | Renal tubular dysfunction and rickets along with liver failure |
Deficiency of GALT enzyme activity | Confirm with elevated succinylacetone and/or biallelic pathogenic FAH variants. |
Classic Galactosemia versus Crigler-Najjar Syndrome
Classic Galactosemia | Crigler-Najjar Syndrome |
|---|---|
Elevated galactose-1-phosphate with mixed hyperbilirubinemia | Isolated unconjugated hyperbilirubinemia with normal galactose metabolites |
Milk-triggered liver disease may include conjugated jaundice, coagulopathy and true sepsis. | Severe jaundice and risk of kernicterus without liver failure or sepsis |
Deficiency of GALT enzyme activity | The isolated unconjugated bilirubin pattern suggests impaired conjugation; UGT1A1 molecular testing can confirm the cause. |